June 3, 2013
J.K. WallWhile Indiana’s governor, legislature and life sciences executives are united behind the proposed Indiana Biosciences
Research Institute, the state of Michigan has a cautionary tale to tell about such an effort.
More
May 30, 2013
J.K. WallThe $360 million initiative will be formally launched on Thursday by Gov. Mike Pence, executives of five major life sciences
companies and officials of the state’s research universities.
More
May 18, 2013
J.K. WallThe future of Indiana’s sprawling health care and life sciences industry might be threatened by an unlikely source:
smartphone apps.
More
May 17, 2013
IBJ convened a panel of experts at its Life Sciences Power Breakfast on May 10 to talk about the industry issues
of venture capital, digital health innovations and research university entrepreneurship.
Panel members included Kristin Eilenberg, CEO, Lodestone Logic, Infuse Accelerator; Philip S. Low, Purdue University professor
of chemistry, founder and chief science officer at Endocyte Inc. and On Target Laboratories LLC; R. Matthew Neff, president,
CHV Capital Inc.; Brian Stemme, project director; BioCrossroads; Brian S. Williams, director, Global Healthcare Strategy,
PricewaterhouseCoopers International Ltd.; and Raul Zaveleta, CEO, Indigo BioSystems Inc.
The following is an unedited transcript of the discussion.
More
February 3, 2013
Associated PressThe state's agriculture department under new Gov. Mike Pence is planning a push into the science behind food production
by trying to build a network of university and commercial researchers for what's being called an Agriculture Innovation
Corridor.
More
February 2, 2013
J.K. WallFrustrated by up-and-down state funding for startup life sciences companies, industry leaders are talking up a plan to create
a dedicated funding stream that could total $30 million a year.
More
January 22, 2013
J.K. WallThe life sciences industry in Indiana employs 55,500 workers paying average wages of more than $88,500 per year, according
to new figures released Tuesday by Indianapolis-based life sciences development group BioCrossroads.
More
January 10, 2013
Local startups Esanex Inc. and Algaeon Inc. have received $500,000 and $250,000, respectively, from Indiana Seed Fund II,
BioCrossroads' second fund to help fledgling life sciences companies.
More
December 18, 2012
IBJ StaffBioCrossroads CEO David Johnson has been chosen president and CEO of the Central Indiana Corporate Partnership, succeeding
Mark Miles, who is leaving the CICP after seven years to become CEO of Hulman & Co.
More
November 3, 2012
J.K. WallBioCrossroads CEO David Johnson sees little conflict as he balances all three in promoting and investing in Indiana life sciences
firms
More
October 29, 2012
J.K. WallThe amount of venture capital invested in medical-device and equipment companies nationally has declined each quarter this
year, reaching levels not seen since 2004, according to data released Oct. 19 by the National Venture Capital Association
and PricewaterhouseCoopers.
More
October 23, 2012
J.K. WallEli Lilly CEO John Lechleiter on Tuesday called for creation of a "world-class" research institute in Indianapolis to bring
together scientists from universities and corporations to develop new medical therapies and companies.
More
August 6, 2012
J.K. WallEven though the potential payoff for health care innovation is less certain these days, the business case for new ways to
produce more food has never been stronger. That’s the analysis that lies behind BioCrossroads' new report an agricultural
innovation.
More
July 28, 2012
J.K. WallResearch and development comes under pressure in an age of austerity.
More
June 25, 2012
J.K. WallA new report shows Indiana’s life sciences companies performed better than their peers around the country—and
far better than the rest of Indiana’s private sector—during the early phases of the economic downturn.
More
April 30, 2012
J.K. WallBioCrossroads Inc. has raised an $8.25 million seed fund in its second attempt to help startup life sciences companies grow
to the point where they can attract venture capital or a corporate funder.
More
February 11, 2012
J.K. WallIn the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies,
an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national
reports on life sciences.
More
February 6, 2012
J.K. WallIndiana companies landed just $14.1 million in venture funding last year, the lowest amount of capital flowing to the
state’s health care sector since BioEnterprises began tracking such deals in 2005.
More
January 14, 2012
J.K. WallA new report by BioCrossroads says 53 percent of the 20,000 jobs in Indiana’s medical-device sector require no more
than a high school education.
More
October 20, 2011
Chris O'MalleyBioCrossroads’ Indiana Seed Fund has invested $300,000 in a startup company chaired by a former Eli Lilly and Co. executive
developing an absorbable stent.
More
October 8, 2011
IBJ StaffThe advocate for the state's life sciences industry has now pulled in more than $25 million from the endowment.
More
July 30, 2011
Maria LaMagnaThe U.S. Food and Drug Administration's growing reputation for unpredictability is spurring some Indianapolis companies to
join counterparts elsewhere and introduce products in Europe. The upshot is that some Americans may never benefit from innovations
occurring in their backyards.
More
July 30, 2011
Chris O'MalleyFormer Eli Lilly and Co. vice president Richard Dimarchi, BioCrossroads President David Johnson, angel investor Oscar Moralez
and Purdue University Senior Vice President Alan Rebar discuss issues ranging from the depth of the life sciences industry
in Indiana to venture capital and Purdue's Discovery Park.
More
July 23, 2011
Scott OlsonThe Indianapolis Convention & Visitors Association plans to attract more life sciences conferences.
More
June 23, 2011
Chris O'MalleyA total of 220 life sciences startups have been launched in Indiana since 2004, or an average of 44 per year, according to
a new report from BioCrossroads that tracked the industry’s growth over the last eight years.
More
Saw the Indy Men's Chorus "Music of Gilbert & Sullivan" at the Indiana Historical Society on Sunday evening.
Temporary workers are not "tools" they are people and companies that keep large amounts of temp staff are cheating.
I miss having them around. I hope one of their stores is in the general Meridian/86th Street area. I will make good use of it.
The Fringe! Plus, the simple fact that there are so many local faves in such close proximity to each other.
I remenber, watching the toll road, being built, through South Bend, when I was 10 years old. I believe, back then that it was estimated, that the toll road, would be paid for in 20 years and then it would be free. I am now 71, what happened? Since the power is in the people, by that, I mean that, we the people are in total control of everything. I, suggest that no one ever use the toll road again, let it go broke. We the people can control the price of everything, from groceries to gas, if we would just do it. If we don't pay the asking price, the sellers will lower the price and if we wait awhile, they will lower the price to what we accept as reasonable. I would like to know why a highway like interstate 94, is so well maintained, a much better highway, than the toll road, but has no tolls. I would also like to know why, a sitting governor, with a term limit, maximum of eight years, can lease, public property, for 75 years. Even though I have transponders in both of my trucks and will not be affected by the increase, I have been and will contine to avoid using the toll road. I make many trips from northern Indiana to Chicago, every year, and I prefer the better highway, I94!